FILE PHOTO: Pfizer vaccine photo illustration
FILE PHOTO: Vials with a sticker reading, “COVID-19 / Coronavirus vaccine / Injection only” and a medical syringe are seen in front of a displayed Pfizer logo in this illustration taken October 31, 2020. REUTERS/Dado Ruvic/File Photo

December 2, 2020

LONDON (Reuters) – Pfizer is seeking full marketing authorisation from Britain for its COVID-19 vaccine, an executive said on Wednesday as the U.S. drugmaker gears up to deliver by the weekend the first shots following approval for emergency use in the country.

The application for full approval is “in parallel” with emergency use, said Berkeley Phillips, medical director of Pfizer UK, in a briefing.

He said regulators will review the same data provided for the emergency use by Pfizer and its partner and BioNTech for the full approval. He did not say when that decision may come.

Deliveries to Britain could not have started until the regulators had given their go ahead, he said. Regulators will assess each batch of the vaccine for quality.

(Reporting by Alistair Smout and Kate Kelland in London, John Miller in Zurich and Ludwig Burger in Frankfurt; Writing by Josephine Mason; Editing by Louise Heavens)

Public Affairs

Sign Up for Our Newsletters

Get notified first!

You May Also Like

Newsom Recall Shows States Can Do More to Protect Constitutional Rights: Dr. Cordie Williams

It’s a ‘shot across the bow’ of politicians who would restrict civic…

Senate Approves $1.9 Trillion COVID-19 Stimulus Package on Party-Line Vote

The Senate approved the $1.9 trillion COVID-19 stimulus package Saturday on a…

Lyfeloop is Best New Social Media App

Lyfeloop has been Named Best New Social Media App while quietly gaining…

Grassroots Rebellion Grows With New Calls to Ban Critical Race Theory from Military, Public Schools

Kevin O’Leary said he was “devastated” when he learned his former football…